_:n87044b2786fb439f85be73c9e92c2a98xb2
<http://schema.org/description>
"Northwest Biotherapeutics reported -91666000 in Equity Capital and Reserves for its second fiscal quarter  of 2022. "
<https://d3fy651gv2fhd3.cloudfront.net/nwbo:us:equity-capital-and-reserves>